Singapore Cell and Gene Therapy (SCGT) Pan Asia Summit 2025 – Pre-Conference Workshop Highlights

Singapore Cell and Gene Therapy (SCGT) Pan Asia Summit 2025 – Pre-Conference Workshop Highlights 🌟

Grateful to have attended the SCGT 2025 Pre-Conference Workshop on 16 July 2025—an insightful day filled with cutting-edge science, innovative tools, and valuable discussions on the future of cell and gene therapy in Asia.

🔑 A major highlight was the keynote by Prof. Shin Kawamata, who shared his deep expertise and emphasized the critical importance of quality control (QC) in iPSC-derived cell products—a powerful reminder that robust QC is the foundation of safe and effective therapies. 🧪✔️

🛠️ We were also privileged to hear from Prof. Han Wei Hou and Prof. Andre Choo, who presented impressive innovations in manufacturing, critical quality attributes (CQA), and analytics for cell therapy products. Their work is truly shaping the next generation of therapies. 🔍📊

📈 Wrapping up with inspiration, Prof. Yie Hou Lee, Prof. Andy Tan, and Prof. Aloysius Ho shared technology advancement in cell scale-up and manufacturing—demonstrating how innovation is driving scalability, accessibility, and real-world clinical impact. ⚙️🏭

💡 Lastly, a wonderful Q&A session spotlight on the collective effort of scientists, engineers, and clinicians working together to transform cell and gene therapy from bench to bedside.